Beijing Datsing Bio-tech Co., Ltd., carrying its products philosophy of learning from nature, is a leading innovative company committed to improving the quality of life. Datsing is committed to the fields of biomedical materials, regenerative medicine and tissue engineering and stem cell and biotherapy.

Datsing Bio-tech is headquartered in Jiahua Plaza, the core area of Zhongguncun Science Park, has built state-of-the-art modern production facilities and R&D laboratories in Beijing and Chongqing respectively. Datsing Bio-tech prides itself on its technological and R&D capability. We boast staffs with master and PHD degrees and R&D teams headed by renowned experts and professors. The team has undertaken numerous research tasks assigned by the Ministry of Science and Technology, the Ministry of Health, Beijing municipal government and the Sichuan provincial government. At present, Datsing Bio-tech has established technological platforms in five areas: Natural extraction of biomaterials, derivative decellularized biomaterials, biominerals and synthetic biomaterials, cell technology and biotherapy technology, the integrated research of materials, cells and biotic factors.

Datsing Bio-tech has acquired 5 product registration licenses with SFDA. They are Teeth desensitizer(Actimins), Absorbable hemostat(Biopaper), Allogenic bone graft(Biogene) and TF (Gene transfected pigskin) More than 10 products are currently in the pipeline and will reach the market in the next three to five years.

In recent years, Datsing is actively promoting partnerships with international medical players in terms of R&D cooperation and business development.